Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Malvern Panalytical and Concept Life Sciences have jointly launched Amplify Analytics - a new range of highly flexible services designed to help pharmaceutical companies rapidly identify those drug candidates that meet bioavailability and ...
read more
Wednesday, January 12, 2022
Malvern Panalytical announced its acquisition of Creoptix AG, a specialist bioanalysis sensor company.
read more
Friday, November 14, 2014
Malvern’s rapidly growing analytical toolkit for all stages of the pharmaceutical and biopharmaceutical product lifecycle will be on show at this year’s AAPS Annual Meeting and Exposition, in San Diego, USA (San Diego Convention Center, 2 - 6 ...
read more
Wednesday, August 24, 2016
Mallinckrodt has entered into a definitive agreement under which it will sell its Nuclear Imaging business to IBA Molecular (IBAM), for approximately $690 million before tax impacts, including up-front and contingent consideration and the assumption ...
read more
Wednesday, December 27, 2017
Mallinckrodt and Sucampo Pharmaceuticals announced they have entered into an agreement under which Mallinckrodt will acquire Sucampo, including its commercial and development assets.
read more
Wednesday, April 04, 2018
Paul R. Carter and Anne C. Whitaker have experience in the branded pharmaceutical industry and will join the Mallinckrodt Board pending shareholder vote at the Annual General Meeting in May, 2018.
read more
Saturday, January 28, 2017
Mallinckrodt has closed the sale of its global Nuclear Imaging business to IBA Molecular (IBAM) for approximately $690 million before tax, including up-front and contingent considerations and the assumption of long-term obligations.
read more
Monday, December 11, 2017
Mallinckrodt has closed the acquisition of Ocera Therapeutics, a clinical stage biopharmaceutical company.
read more
Monday, September 16, 2019
Mallinckrodt has entered into a definitive agreement to sell its wholly owned subsidiary BioVectra to an affiliate of H.I.G. Capital for approximately $250 million.
read more
Juniper Pharma Services has reached a key milestone in its work with CrystecPharma and the AMSCI to create a new platform to accelerate drug development.
read more
Thursday, August 02, 2018
LSPediA announced a new business relationship with MAGNA Pharmaceuticals.
read more
Alcami has reached an agreement to be acquired by Madison Dearborn Partners (MDP).
read more
Made Scientific recently held a ribbon-cutting ceremony to commemorate the grand opening of its new 60,000 sq. ft. GMP manufacturing facility and headquarters in Princeton, New Jersey.
read more
Thursday, August 28, 2025
Made Scientific announced the formation of its Scientific Advisory Board (SAB) with the appointments of Miguel Forte, M.D., Ph.D., Paul K. Wotton, Ph.D., Shishir Gadam, Ph.D., and Young K. Hong M.D.
read more
Made Scientific announced a significant expansion of its Princeton, New Jersey facility to meet increasing demand from late-phase and commercial clients and support the anticipated rise in approved advanced therapies.
read more